Daniel Raúl Grinberg Vaisman
Jefe de Grupo Senior
Research group
Research line:
Lysosomal diseases, bone diseases, intellectual disability
The researcher Daniel Grinberg graduated in Biology in 1981 from the University of Barcelona and obtained his PhD in Genetics from the University of Barcelona in 1986.
Between 1987 and 1990, he undertook a postdoctoral stay at the Imperial Cancer Reserch Fund in London where he studied the transcriptional regulation mechanisms of the int-2 gene responsible for the mouse breast tumor.
Since 1990 he has been a professor at the University of Barcelona as a professor until 2008 and as a cathedratic professor from 2008 until today. He was Director of the Department of Genetics at the University of Barcelona from 2008 to 2012 and member of the Scientific Program Committee of the European Society of Human Genetics from 2012 to 2016.
He is currently leading the research group on Human Molecular Genetics, a group recognized as a quality group by the Generalitat de Catalunya (2017 SGR 738), and a group from the CIBERER, the IBUB and the IRSJD, where he studies the genetic and molecular bases of monogenic diseases and complexes, the generation of models and new therapeutic strategies.
Professional network profiles
Last Publications
- Garcia-Giralt N, Roca N, Abril JF, Martinez-Gil N, Ovejero D, Castañeda S, Nogues X, Grinberg-Vaisman DR, Balcells S and Raquel Rabionet Janssen Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment. GENES . 13(1): .
- Martinez N, Ugartondo N, Grinberg-Vaisman DR and Balcells S Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis. GENES . 13(1): .
- Rauner M, Foessl I, Formosa MM, Kague E, Prijatelj V, Lopez NA, Banerjee B, Bergen D, Busse B, Calado Â, Douni E, Gabet Y, Giralt NG, Grinberg-Vaisman DR, Lovsin NM, Solan XN, Ostanek B, Pavlos NJ, Rivadeneira F, Soldatovic I, van de Peppel J, van der Eerden B, van Hul W, Balcells S, Marc J, Reppe S, Søe K and Karasik D Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques. Frontiers in Endocrinology . 12: 731217-731217.